FDA Urged to Update Chantrix Warning Label

“Scientists say the U.S. Food and Drug Administration (FDA) should take warnings about the stop-smoking drug Chantix up a notch, citing data showing that the drug increases suicidal behavior and depression far more than other drugs and methods designed to help smokers quit,” as reported by ABC News correspondant, Carrie Gann.

“Chantix, also called varenicline, has been hotly debated since 2007, when experts first raised questions about the long-term safety of the drug and its connection to cardiovascular problems and vision lapses. Since then, studies have reported that patients taking Chantix are at increased risk of depression and suicidal thoughts. Anecdotally, patients report wild dreams, inexplicable violent behavior and other psychological disturbances while on the drug.”  To continue reading, go to http://abcnews.go.com/Health/chantix-dangers-government-attention-study/story?id=14868835#.TrmZwXLup9N.

Drugs and pharmaceuticals are often at the center of product liability cases.  Drug manufacturers have a duty to test the medicines before releasing them to the market and a duty to warn users about known side effects. 

If you believe you may have been harmed by a drug that you were legally prescribed by a licensed medical practitioner, The NH Lawyer Referral Service can refer you to competent  attorneys who have experience with pharmaceutical liability cases.   Call LRS now at 603-229-0002 or request an online referral at https://www.newhampshirelawyerreferral.com/contact-us.